Related references
Note: Only part of the references are listed.Chemoresistance in gliomas
Chen Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Eukaryotic DNA damage tolerance and translesion syntheses through covalent modifications of PCNA
Parker L. Andersen et al.
CELL RESEARCH (2008)
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Frank B. Furnari et al.
GENES & DEVELOPMENT (2007)
shRNA and siRNA delivery to the brain
William M. Pardridge
ADVANCED DRUG DELIVERY REVIEWS (2007)
In vivo imaging of siRNA delivery and silencing in tumors
Zdravka Medarova et al.
NATURE MEDICINE (2007)
Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer
Caroline Rimkus et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Strategies for silencing human disease using RNA interference
Daniel H. Kim et al.
NATURE REVIEWS GENETICS (2007)
Translesion synthesis in mammalian cells
Alan R. Lehmann
EXPERIMENTAL CELL RESEARCH (2006)
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts
Marius Grzelinski et al.
HUMAN GENE THERAPY (2006)
Lysine 63-polyubiquitination guards against translesion synthesis-induced mutations
Roland K. Chiu et al.
PLOS GENETICS (2006)
Human REV1 modulates the cytotoxicity and mutagenicity of cisplatin in human ovarian carcinoma cells
XJ Lin et al.
MOLECULAR PHARMACOLOGY (2006)
Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents
HW Cheung et al.
CANCER RESEARCH (2006)
The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death
F Manero et al.
CANCER RESEARCH (2006)
DNA polymerase η, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation
G Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability
BB Yuan et al.
CLINICAL CANCER RESEARCH (2006)
DNA polymerase ζ accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair
XJ Lin et al.
CLINICAL CANCER RESEARCH (2006)
Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas
L. Barzon et al.
CANCER GENE THERAPY (2006)
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
H Bronger et al.
CANCER RESEARCH (2005)
Multiple roles of vertebrate REV genes in DNA repair and recombination
T Okada et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Suppression of hREV1 expression reduces the rate at which human ovarian carcinoma cells acquire resistance to cisplatin
T Okuda et al.
MOLECULAR PHARMACOLOGY (2005)
The overexpression of specialized DNA polymerases in cancer
MR Albertella et al.
DNA REPAIR (2005)
Down-regulation of DNA polymerases κ, η, ι, and ξ in human lung, stomach, and colorectal cancers
QR Pan et al.
CANCER LETTERS (2005)
DNA polymerase ζ regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance
F Wu et al.
CANCER RESEARCH (2004)
Chemotherapeutic agents that induce mitochondrial apoptosis
T Asakura et al.
CURRENT CANCER DRUG TARGETS (2004)
Cytokine gene therapy for malignant glioma
H Okada et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2004)
Multiple roles of Rev3, the catalytic subunit of pole in maintaining genome stability in vertebrates
E Sonoda et al.
EMBO JOURNAL (2003)
Role of mitochondria in toxic cell death
JD Robertson et al.
TOXICOLOGY (2002)
Brain-tumour drug resistance: the bare essentials
M Bredel et al.
LANCET ONCOLOGY (2002)
Involvement of mouse Rev3 in tolerance of endogenous and exogenous DNA damage
PPH Van Sloun et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Anticancer drug resistance in primary human brain tumors
M Bredel
BRAIN RESEARCH REVIEWS (2001)
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
JL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
